MDGL
NASDAQ · Biotechnology
Madrigal Pharmaceuticals Inc
$509.76
-3.67 (-0.71%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-13.52%
1Y
+83.60%
YTD
-14.16%
Open$516.83
Previous Close$513.43
Day High$527.71
Day Low$509.07
52W High$615.00
52W Low$275.00
Volume—
Avg Volume287.4K
Market Cap11.66B
P/E Ratio—
EPS$-13.63
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$526.21
Below
SMA 200
$421.32
Above
RSI (14)
32.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
-76.5% upside
Current
$509.76
$509.76
Target
$119.83
$119.83
$78.20
$119.83 avg
$127.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 984.95M | 3.52B | 3.21B |
| Net Income | -296,267,510 | -1,086,916,353 | -1,008,552,409 |
| Profit Margin | -30.1% | -30.9% | -31.4% |
| EBITDA | -309,715,875 | -994,214,061 | -913,486,769 |
| Free Cash Flow | — | -874,407,524 | -958,278,915 |
| Rev Growth | — | +9.6% | -7.9% |
| Debt/Equity | 0.56 | 0.46 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |